According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.76. In 2022 the company made an earnings per share (EPS) of -$5.15 an increase over its 2021 EPS that were of -$17.01.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.57 | -30.59% |
2022 | -$5.15 | -69.74% |
2021 | -$17.01 |